Investors/Media

Spruce Biosciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet need. Learn more about our clinical pipeline here.

Corporate Presentation

Stock Information

Change

High

Minimum 15 minutes delayed. Source: LSEG

Events and Presentations

November 10, 2026 at 11:30 AM EST
Guggenheim 3rd Annual Healthcare Innovation Sign up
October 22, 2026
Craig-Hallum Biotech Catalyst Conference Sign up
September 15, 2026 at 2:00 PM EDT
H.C. Wainwright 28th Annual Global Investment Conference Sign up